-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. In ’t Veld, SGJG, Arkani, M, Post, E, Antunes-Ferreira, M, D’Ambrosi, S, Vessies, DCL, et al.. Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell 2022;40:999–1009.e6. https://doi.org/10.1016/j.ccell.2022.08.006.Search in Google Scholar PubMed
2. Fernandez-Uriarte, A, Pons-Belda, OD, Diamandis, EP. Cancer screening companies are rapidly proliferating: are they ready for business? Cancer Epidemiol Biomarkers Prev 2022;31:1146–50. https://doi.org/10.1158/1055-9965.epi-22-0102.Search in Google Scholar
3. Anonymous. NCI to study cancer blood tests. Science 2022;377:8.Search in Google Scholar
4. Wilson, JMG, Jungner, G, World Health Organization. Principles and practice of screening for disease; 1968. Available from: https://apps.who.int/iris/handle/10665/37650.Search in Google Scholar
5. Fiala, C, Diamandis, EP. A multi-cancer detection test: focus on the positive predictive value. Ann Oncol 2020;31:1267–8. https://doi.org/10.1016/j.annonc.2020.05.028.Search in Google Scholar PubMed
6. Fiala, C, Diamandis, EP. P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screening. Clin Biochem 2020;77:62. https://doi.org/10.1016/j.clinbiochem.2020.01.002.Search in Google Scholar PubMed
7. Fiala, C, Diamandis, EP. Can a broad molecular screen based on circulating tumor DNA aid in early cancer detection? J Appl Lab Med 2020;5:1372–7. https://doi.org/10.1093/jalm/jfaa138.Search in Google Scholar PubMed
8. Fiala, C, Taher, J, Diamandis, EP. P4 medicine or O4 medicine? Hippocrates provides the answer. J Appl Lab Med 2019;4:108–19. https://doi.org/10.1373/jalm.2018.028613.Search in Google Scholar PubMed
9. Duffy, MJ, Diamandis, EP, Crown, J. Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon? Clin Chem Lab Med 2019;59:1353–61.10.1515/cclm-2021-0171Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
